News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MLC Dx, Inc. Raises $6M



8/16/2010 7:38:46 AM

Xconomy -- MLC Dx, a San Francisco-based maker of molecular diagnostics, has secured $5.9 million in a Series B financing, according to a report in VentureWire. Mohr Davidow Ventures participated in the round, VentureWire said. MLC Dx is led by CEO Thomas Willis, who previously ran another Mohr Davidow portfolio company, ParAllelle Bioscience, before it was sold to Santa Clara, CA-based Affymetrix in 2005.

Read at Xconomy


comments powered by Disqus
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES